Frank Morgan analyst

Currently out of the existing stock ratings of Frank Morgan, 137 are a BUY (73.26%), 49 are a HOLD (26.2%), 1 are a SELL (0.53%).

Frank Morgan

Work Performance Price Targets & Ratings Chart

Analyst Frank Morgan, carries an average stock price target met ratio of 67.93% that have a potential upside of 27.76% achieved within 287 days. Previously, Frank Morgan worked at RBC.

Frank Morgan’s has documented 374 price targets and ratings displayed on 32 stocks. The coverage was on Healthcare, Financial Services, Communication Services, Industrials, Consumer Cyclical sectors.

Most recent stock forecast was given on GOCO, GoHealth at 20-Mar-2024.

Wall Street Analyst Frank Morgan

Analyst best performing recommendations are on SLQT (SELECTQUOTE).
The best stock recommendation documented was for SLQT (SELECTQUOTE) at 8/26/2021. The price target of $13 was fulfilled within 14 days with a profit of $5.11 (64.77%) receiving and performance score of 46.26.

Average potential price target upside

ACHC Acadia Healthcare Company ADUS Addus HomeCare AMED Amedisys ANTM Anthem BKD Brookdale Senior Living CHE Chemed Corp CI Cigna Corp CYH Community Health Systems DVA DaVita HealthCare Partners ENSG The Ensign Group FMS Fresenius Medical Care GOCO GoHealth HCA HCA Holdings HUM Humana LHCG LHC Group MAX MediaAlpha PNTG Pennant Group SLQT Selectquote THC Tenet Healthcare UHS Universal Health Services UNH UnitedHealth Group BHG Bright Health Group CVS CVS Health Corp EHC Encompass Health Corp EHTH eHealth EVHC Envision Healthcare Holdings SEM Select Medical Holdings AVAH Aveanna Healthcare Holdings ELV Elevance Health SGRY Surgery Partners AME Ametek AN AutoNation

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 03-Mar-2026

$20

$-3.96 (-16.53%)

$27

1 months 6 days ago
(03-Mar-2026)

5/17 (29.41%)

$-2.99 (-13.01%)

133

Hold Since 26-Feb-2026

$22

$-1.96 (-8.18%)

$40

1 months 14 days ago
(26-Feb-2026)

9/14 (64.29%)

$-0.29 (-1.30%)

360

Buy Since 14-Jan-2026

$28

$4.04 (16.86%)

$17

1 months 14 days ago
(26-Feb-2026)

3/15 (20%)

$5.71 (25.62%)

77

Buy Since 09-Apr-2025

$22

$-1.96 (-8.18%)

$27

1 months 17 days ago
(23-Feb-2026)

1/4 (25%)

$4.62 (26.58%)

3

Buy Since 04-Jun-2015

$15

$-8.96 (-37.40%)

$105

2 months 18 days ago
(22-Jan-2026)

19/21 (90.48%)

$-0.15 (-0.99%)

1043

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Frank Morgan?

On 2009

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?